Suppr超能文献

转甲状腺素蛋白心脏淀粉样变性患者的左束支区域起搏:病例系列

Left bundle branch area pacing in patients with transthyretin cardiac amyloidosis: a case series.

作者信息

Miyajima Keisuke, Kobayashi Wakaba, Hakamata Shogo, Takazawa Yasukazu, Kawaguchi Yoshitaka, Wakabayashi Yasushi, Maekawa Yuichiro

机构信息

Department of Cardiology, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ward, Hamamatsu, Shizuoka 433-8558, Japan.

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

出版信息

Eur Heart J Case Rep. 2025 Jan 15;9(1):ytae677. doi: 10.1093/ehjcr/ytae677. eCollection 2025 Jan.

Abstract

BACKGROUND

Transthyretin cardiac amyloidosis is associated with various arrhythmias, including atrioventricular block. Despite this correlation, established treatments for transthyretin cardiac amyloidosis-associated arrhythmias are lacking. Left bundle branch area pacing is a promising physiological pacing technique.

CASE SUMMARY

This case series describes three instances of successful left bundle branch area pacing in patients with transthyretin cardiac amyloidosis presenting with atrioventricular block. Despite significant ventricular septal hypertrophy across all cases, left bundle branch area pacing was implemented effectively without complications.

DISCUSSION

Traditional pacing strategies in transthyretin cardiac amyloidosis, such as right ventricular pacing, have been associated with a reduced left ventricular ejection fraction and worsening heart failure. Although biventricular pacing has been explored, the supporting evidence remains limited and inconclusive. Recent studies have suggested that left bundle branch area pacing poses a lower risk of inducing heart failure than biventricular pacing. Our findings support the safety and efficacy of the left bundle branch area pacing in patients with transthyretin cardiac amyloidosis-related atrioventricular blocks and underscore its viability as a pacing strategy.

摘要

背景

转甲状腺素蛋白心脏淀粉样变性与各种心律失常相关,包括房室传导阻滞。尽管存在这种相关性,但缺乏针对转甲状腺素蛋白心脏淀粉样变性相关心律失常的既定治疗方法。左束支区域起搏是一种有前景的生理性起搏技术。

病例总结

本病例系列描述了3例转甲状腺素蛋白心脏淀粉样变性伴房室传导阻滞患者成功进行左束支区域起搏的情况。尽管所有病例均存在明显的室间隔肥厚,但左束支区域起搏实施有效,无并发症发生。

讨论

转甲状腺素蛋白心脏淀粉样变性的传统起搏策略,如右心室起搏,与左心室射血分数降低和心力衰竭恶化有关。尽管已经探索了双心室起搏,但其支持证据仍然有限且尚无定论。最近的研究表明,左束支区域起搏诱发心力衰竭的风险低于双心室起搏。我们的研究结果支持左束支区域起搏在转甲状腺素蛋白心脏淀粉样变性相关房室传导阻滞患者中的安全性和有效性,并强调了其作为一种起搏策略的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22c6/11733915/4ef74bf211dd/ytae677il2.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验